Cotrimoxazole and targeted antibiotic prophylaxis for transrectal prostate biopsy: a single-center study
ConclusionsUsing cotrimoxazole as PAP for TRPB in cases without multiresistant gram-negatives in pre-interventional urine cultures or rectal swabs seems feasible and practical.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
More News: Amoxicillin | Cancer | Cancer & Oncology | Gastroenteritis | Microbiology | Prostate Cancer | Study | Urology & Nephrology